title: Management of hereditary angioedema with C1-inhibitor concentrate during two successive pregnancies.
authors.affiliation: Gordon Sussman Clinical Research Inc, Toronto, Canada.
authors.forename: Wai
authors.initials: W
authors.lastname: Chan
authors.forename: Noam
authors.initials: N
authors.lastname: Berlin
authors.forename: Gordon L
authors.initials: GL
authors.lastname: Sussman
mesh_terms: D000293:Adolescent; D000328:Adult; D050718:Complement C1 Inhibitor Protein / Q000627:therapeutic use*; D051056:Complement Inactivating Agents / Q000627:therapeutic use*; D003613:Danazol / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D056829:Hereditary Angioedema Types I and II / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*
chemical_list: D050718:Complement C1 Inhibitor Protein; D051056:Complement Inactivating Agents; D004965:Estrogen Antagonists; D003613:Danazol